# Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis

> **NCT06197009** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sinocelltech Ltd.** · enrollment: 168 (estimated)

## Conditions studied

- Axial Spondyloarthritis

## Interventions

- **DRUG:** SCT650C

## Key facts

- **NCT ID:** NCT06197009
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06197009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06197009, "Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06197009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*